| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | President and CEO | Executive Chairman
3 companies
Christoph H Westphal last filed a Form 4 in July 2021, as 10% Owner at TCRX. The filings on record cover 3 companies. From January 2015 to July 2021, the filings on record show 62 open-market purchases and 1 sale. Christoph H Westphal's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 665,224 shares of VSTM. Net of sales, the VSTM filings show accumulation of 1,230,769 shares.
Shares as reported in the last Form 4 for each company; the most recent is from July 2021. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 6, 2015 | DCOY Salarius Pharmaceuticals, Inc. | President and CEO | Buy | 262 | $21.18 | $5,547.95 | - | |
| Mar 30, 2015 | DCOY Salarius Pharmaceuticals, Inc. | President and CEO | Buy | 272 | $20.52 | $5,581.06 | - | |
| Jan 28, 2015 | VSTM Verastem, Inc. | Executive Chairman | Buy | 1,230,769 | $6.50 | $7,999,998.50 | New |